Panel: Compulsory Licensing Could Address High-Priced Medicines In Europe 28/05/2015 by Eimear Murphy for Intellectual Property Watch 3 Comments The high prices of medicine, which affects access to affordable medicine, was a theme of the annual World Health Assembly over the past week. In one side event, a panel discussed compulsory licensing as a vehicle to be used in combatting the high prices of medicine, not only in developing countries, but in Europe.
World Health Assembly Concludes With Actions On Range Of Issues 27/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The 68th World Health Assembly (WHA), which took place from 18-26 May, was characterised as one of the most successful annual assemblies ever by Margaret Chan, World Health Organization director general. From the standpoint of intellectual property, access and innovation, this may be debatable. Below is a guide to the main accomplishments highlighted by Intellectual Property Watch. These include: action plans to fight antibiotic resistance and to boost vaccinations, extension of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA), incremental progress on alternative research and development for neglected diseases, status of the pandemic influenza preparedness framework, response to emergencies like Ebola, and WHO’s relationship with lobbyists and donors.
WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable 25/05/2015 by William New, Intellectual Property Watch 1 Comment The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.
WHO Advances R&D Financing Effort; Global R&D Observatory To Launch In January 24/05/2015 by Catherine Saez and William New, Intellectual Property Watch 2 Comments World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.
Review Of WHO Mechanism To Fight Substandard Medicines Postponed Until 2017 22/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment World Health Organization delegates today agreed in committee to postpone until 2017 the review of a mechanism that had been set up to help countries deal with substandard and fake medicines.
WHO Debates Plan To Fight Antibiotic Resistance 22/05/2015 by Eimear Murphy for Intellectual Property Watch 2 Comments World Health Organization members this week are debating a plan to address the global problem of increasing resistance to existing antibiotics and the lack of new treatments to replace them. Today, discussions on antimicrobial resistance went to informals to try to resolve outstanding issues.
European Council Takes Action To Advance Marrakesh Treaty For Blind Persons 21/05/2015 by Intellectual Property Watch 1 Comment The European Council of member states yesterday adopted a decision asking the European Commission to draft legislation on Europe’s ratification of the Marrakesh Treaty on increasing access to publications for blind and visually impaired readers.
Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug 20/05/2015 by Intellectual Property Watch Leave a Comment Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in the United States and elsewhere. Now a group of health advocates has challenged Gilead’s patent applications in five emerging economies.
New Act Protecting Geographical Indications Adopted At WIPO 20/05/2015 by Catherine Saez, Intellectual Property Watch 2 Comments Today, a small number of World Intellectual Property Organization members adopted a new Geneva Act of a treaty protecting appellations of origin and geographical indications. The Act is the revision of a previous treaty which only covered appellations of origin. This adoption was made to the dismay of other WIPO members, which despite efforts to accommodate their views could not reconcile being denied the right to vote in a United Nations body. They said the agreement among a few members could affect all.
Statement: Blumenthal Offers Amendment On Trade Transparency 19/05/2015 by Intellectual Property Watch Leave a Comment Senators Blumenthal, Brown, Baldwin, and Udall introduced today a trade negotiation transparency bill that would require that all formal U.S. proposals for trade agreement restrictions on domestic regulations be posted on a website. This is a common sense policy that should be broadly supported. The bill would require policies similar to the transparency policies currently followed by the European Union and by intergovernmental organizations that set similar minimum regulatory standards. But it would be a major change in the current process for trade negotiations followed by the U.S. Trade Representative, which are infamously secretive, write Sean Flynn and David Levine.